心力衰竭 (HF)是一种常见、严重危害人民身体健康的疾病 ,在欧洲心衰治疗指南中把HF视为比癌症更为预后不良 ,比心肌梗塞更为可怕的疾病 ,估计发病率为 0 .3%～ 2 % ,心功能IV级者 ,1年死亡率为 5 0 %。2 0世纪最后 2 0年对HF治疗的研究应用有极大的时展 ,主要是血管紧张素转换 Heart failure (HF) is a common and serious detriment to people’s health. HF is considered as a more adverse prognosis and a more terrible disease than myocardial infarction in the European guidelines for the treatment of heart failure. The estimated incidence rate is 0 .3% ~ 2%, grade IV heart function, one-year mortality rate was 50%. The study of HF therapy in the last 20 years of the 20th century has had a tremendous timeline to study, mainly the conversion of angiotensin